Gastrointestinal stromal tumor | Tumor

CURE’s gastrointestinal stromal tumor page features the latest cancer news and updates on gastrointestinal stromal tumors Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in the gastrointestinal stromal tumor.

Surgery May Extend Survival For Patients with GIST and Liver Metastases

January 16th 2025, 4:00pm

Article

For patients with gastrointestinal stromal tumors with liver metastases, treatment with surgery and chemotherapy has been found to have survival benefits.

Machine Learning Predicts Gleevec Nonadherence in Patients With GIST

January 15th 2025, 4:00pm

Article

Indicators for Gleevec nonadherence were cognitive functioning, global health status score, social support, gender and others in patients with GIST.

Laparoscopic Wedge and Endoscopic Resection Are Safe, Feasible in Gastric GISTs

January 9th 2025, 8:00pm

Article

Both laparoscopic wedge and endoscopic resection are safe and feasible treatment approaches for patients with gastric gastrointestinal stromal tumors.

Gleevec Interruption in GIST Associated with Resistance, Recurrence, Death

October 2nd 2024, 7:00pm

Article

Researchers are advising against the interruption of treatment with Gleevec among patients with advanced gastrointestinal stromal tumors.

Grace Helbig, Joaquin Castro Announces Cancer Diagnoses and More

July 7th 2023, 3:00pm

Article

From YouTuber Grace Helbig announcing her cancer diagnosis to the NFL’s Foster Moreau being in full remission, here’s what’s happening in the oncology space this week.

Lining Up New Options for GIST

June 14th 2023, 7:00pm

Article

Patients with GIST have more treatment options than ever, with others currently under development.

Qinlock Becomes Preferred Second-Line Drug for GIST Subset

March 21st 2023, 9:00pm

Article

The National Comprehensive Cancer Network updated their guidelines to state that Qinlock is the recommended second-line treatment for patients with Sutent-intolerant gastrointestinal stromal tumors.

Cancer Helped Me Acknowledge and Appreciate My Dual Identity

March 7th 2023, 2:00pm

Article

As a doctor, I’m used to providing medical care, but once I was diagnosed with cancer, I became a patient — someone receiving medical care, too.

Many Survivors of GISTs, a Rare Cancer, May Experience Cancer-Related Cognitive Impairments After Treatment

October 5th 2022, 3:00pm

Article

Nearly two thirds of patients with GISTs — a rare type of cancer that often begins in the digestive system — indicated that their overall quality of life after treatment had been affected by cancer-related cognitive impairments, also referred to as “chemo brain,” according to analysis of survey data.

GIST Location Predicts Tumor Mutation Profile and Drug Sensitivity

August 13th 2021, 9:00pm

Article

The location of gastrointestinal stromal tumors in the stomach predicts the mutation profile and drug sensitivity, which can provide direction for treatment decisions and selective genomic testing.